Akoya Biosciences Inc (AKYA)

Jan 10, 2025, 5:35 PM EST - 7 days ago

AKOYA BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Akoya Biosciences, Inc. - AKYA

QTRX

Jan 10, 2025, 7:00 AM EST - 7 days ago

Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers

QTRX

Dec 10, 2024, 8:15 AM EST - 5 weeks ago

Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions

Nov 14, 2024, 9:43 PM EST - 2 months ago

Akoya Biosciences, Inc. (AKYA) Q3 2024 Earnings Call Transcript

Nov 14, 2024, 4:00 PM EST - 2 months ago

Akoya Biosciences Reports Third Quarter 2024 Financial Results

Oct 28, 2024, 8:30 AM EDT - 2 months ago

Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024

Oct 7, 2024, 8:00 AM EDT - 3 months ago

Akoya's Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy

Oct 3, 2024, 4:00 PM EDT - 3 months ago

Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors

Aug 5, 2024, 10:19 PM EDT - 5 months ago

Akoya Biosciences, Inc. (AKYA) Q2 2024 Earnings Call Transcript

Aug 5, 2024, 4:00 PM EDT - 5 months ago

Akoya Biosciences Reports Second Quarter 2024 Financial Results

Jul 15, 2024, 4:00 PM EDT - 6 months ago

Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences

May 23, 2024, 9:17 AM EDT - 8 months ago

Lab Instrument Industry Update - New Commercial Entrants

BNGO CTKB DHR LAB MASS OMIC QGEN

May 17, 2024, 8:36 PM EDT - 8 months ago

Akoya Biosciences, Inc. (AKYA) Q1 2024 Earnings Call Transcript

May 13, 2024, 4:00 PM EDT - 8 months ago

Akoya Biosciences Reports First Quarter 2024 Financial Results

May 9, 2024, 8:00 AM EDT - 9 months ago

Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients

May 6, 2024, 8:00 AM EDT - 9 months ago

Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts

May 2, 2024, 8:00 AM EDT - 9 months ago

Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows

Apr 22, 2024, 4:05 PM EDT - 9 months ago

Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024

Apr 5, 2024, 8:00 AM EDT - 10 months ago

Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale

Mar 19, 2024, 7:00 AM EDT - 10 months ago

Akoya Biosciences Names BostonGene as a Qualified CRO Service Provider

Mar 4, 2024, 8:17 PM EST - 11 months ago

Akoya Biosciences, Inc. (AKYA) Q4 2023 Earnings Call Transcript

Mar 4, 2024, 4:05 PM EST - 11 months ago

Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook

Feb 8, 2024, 4:05 PM EST - 1 year ago

Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference

Jan 18, 2024, 8:00 AM EST - 1 year ago

Akoya Biosciences' Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases

Jan 10, 2024, 8:00 AM EST - 1 year ago

Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D.

Jan 7, 2024, 8:00 AM EST - 1 year ago

Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform

Jan 7, 2024, 8:00 AM EST - 1 year ago

Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook

Jan 7, 2024, 8:00 AM EST - 1 year ago

Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow

Dec 20, 2023, 8:05 AM EST - 1 year ago

Akoya to Participate at 42nd Annual J.P. Morgan Healthcare Conference

Dec 7, 2023, 7:45 AM EST - 1 year ago

Akoya Biosciences: 2024 Could Be The Year To Own Their Stock

Nov 11, 2023, 12:49 AM EST - 1 year ago

Akoya Biosciences, Inc. (AKYA) Q3 2023 Earnings Call Transcript

Nov 8, 2023, 4:00 PM EST - 1 year ago

Akoya Reports Record Revenue in the Third Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance

Nov 2, 2023, 8:00 AM EDT - 1 year ago

Akoya to Participate at Three Upcoming Investor Conferences

Oct 31, 2023, 9:00 AM EDT - 1 year ago

Akoya Biosciences to Showcase New Spatial Biology 2.0 Solutions and Spatial Phenotyping Data at SITC 2023

Oct 17, 2023, 10:22 AM EDT - 1 year ago

Akoya Biosciences Announces Peer-Reviewed Publication Using Ultrahigh-Plex Spatial Phenotyping of Head and Neck Cancer to Identify Distinct Immune and Metabolic Signatures

Oct 11, 2023, 4:05 PM EDT - 1 year ago

Akoya to Report Third Quarter 2023 Financial Results on November 8th, 2023

Sep 19, 2023, 8:00 AM EDT - 1 year ago

Akoya Biosciences Sets a New Standard for Scaling Spatial Biology with the Launch of 2.0 Platforms

Aug 7, 2023, 10:25 PM EDT - 1 year ago

Akoya Biosciences, Inc. (AKYA) Q2 2023 Earnings Call Transcript

Aug 7, 2023, 4:05 PM EDT - 1 year ago

Akoya Reports Record Revenue in the Second Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance

Aug 7, 2023, 8:05 AM EDT - 1 year ago

Akoya Biosciences Announces Milestone of 1,000 Peer-Reviewed Publications Citing Use of its Spatial Biology Technologies

Aug 1, 2023, 1:59 AM EDT - 1 year ago

Strong Small-Cap Insider Buys: Q2 2023

AAT AVD CNNE DOMO EYE GSAT HTLD

Jul 12, 2023, 8:05 AM EDT - 1 year ago

Akoya to Report Second Quarter 2023 Financial Results on August 7th, 2023

Jun 12, 2023, 4:05 PM EDT - 1 year ago

Akoya to Participate at Two Upcoming Investor Conferences

Jun 8, 2023, 12:55 AM EDT - 1 year ago

Akoya Biosciences Announces Pricing of Public Offering of Common Stock

Jun 7, 2023, 8:15 PM EDT - 1 year ago

Akoya Biosciences shares fall 10% on executive exits, stock offering

Jun 7, 2023, 4:08 PM EDT - 1 year ago

Akoya Biosciences Announces Public Offering of Common Stock

May 9, 2023, 2:12 AM EDT - 1 year ago

Akoya Biosciences, Inc. (AKYA) Q1 2023 Earnings Call Transcript

May 8, 2023, 4:05 PM EDT - 1 year ago

Akoya Reports Record Revenue in the First Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance